AstraZeneca Plc (NASDAQ: AZN)
AstraZeneca Plc Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
AstraZeneca Plc Company Info
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
News & Analysis
The Largest Healthcare Companies by Market Cap in July 2025
Eli Lilly, Johnson & Johnson, and AbbVie command the healthcare sector.
Which Company Owns Corona Beer?
Why AstraZeneca Stock Got Thumped on Thursday
Why AstraZeneca Stock Topped the Market on Tuesday
3 No-Brainer Stocks to Buy for Under $100 Right Now
Which Company Owns Jeep?
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
Why Roche Holding, Eli Lilly, and AstraZeneca Stocks Dropped Today
Might the tariff risk for pharmaceutical stocks be less than you think?
Valuation
Podcast Episodes
Talking About Vaccine News, Oil Predictions, and More
Discover why the stock price movement of AstraZeneca may be misleading.
Is Biopharma Immune to Brexit Fallout?
Digesting how the U.K. decision to exit the EU could affect healthcare stocks here and abroad.
Earnings Transcripts
AstraZeneca Plc (AZN) Q4 2024 Earnings Call Transcript
AZN earnings call for the period ending December 31, 2024.
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
AZN earnings call for the period ending September 30, 2024.
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
AZN earnings call for the period ending June 30, 2024.
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
AZN earnings call for the period ending March 31, 2024.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.